A Systematic Literature Review on the Economic Burden of Sjögren's Disease.

What was studied

This review looked at the money burden of Sjögren's disease for patients. It searched MEDLINE and Embase for studies from 2014 to 2025. It also searched other sources, such as Google Scholar and conference papers. The team pulled out data on health care use, direct costs and lost work. They also held one focus group of patients.

What they found

49 studies reported on the economic burden. 27 reported health care use. 21 reported direct or indirect costs. 16 looked at lost productivity. Most came from North America and Europe. Direct costs were 1.6 to 3.1 times higher than in people without it. Indirect costs ran about 2 times higher. Lost productivity drove this. The focus group told of frequent emergency care, high costs and lost work.

What it means for patients

The authors say the disease brings measurable health care costs and lost productivity. They say it brings a notable financial burden for people and for health systems.

Why it is not certain yet

The size of the extra cost varied across studies, as the ranges show. The studies came from many places, mostly North America and Europe. The focus group gives personal views, not measured costs. A review can only be as good as the studies in it.

Source

A Systematic Literature Review on the Economic Burden of Sjögren's Disease.

We restate facts from the source record in our own words. The original wording belongs to its publisher.